CompletedNCT00167362
Cognitive enhancement therapy for early-stage schizophrenia
About this title
Read the official source — NCT00167362Behavioural studyAges 16–51United States
Understand this study
Who was this study for?
Listed age limits: 16 years to 51 years.
- Listed locations
- PittsburghSee all locations and recruitment
Study information
Study start dateAugust 2001
- Recruitment status
- Completed
- Enrollment listed in the registry
- 67
- Sponsor
- Beth Israel Deaconess Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Behavioral
- Intervention type
- Behavioural
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 16 Years to 51 Years
- Official registry ID
- NCT00167362
- Official title
Show the full official title
Rehabilitation, Brain Function and Early Schizophrenia
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Pittsburgh
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Beth Israel Deaconess Medical Center, a hospital or academic medical center.
Who was this study for?
Listed age limits: 16 years to 51 years.
